Other key activating receptors, such as natural cytotoxicity receptors or NCRs (NKp30, NKp44, and NKp46) are downregulated in acute myeloid leukemia (AML) correlating with poor prognosis and lower survival rates [37]. The gene discussed is NCR3; the disease is acute myeloid leukemia.